Invention Grant
- Patent Title: Indazoles
-
Application No.: US15505345Application Date: 2015-07-30
-
Publication No.: US09862717B2Publication Date: 2018-01-09
- Inventor: Kai Schiemann , Aurelie Mallinger
- Applicant: Merck Patent GmbH , Cancer Research Technology Ltd.
- Applicant Address: DE Darmstadt GB London
- Assignee: Merck Patent GmbH,Cancer Research Technology Limited
- Current Assignee: Merck Patent GmbH,Cancer Research Technology Limited
- Current Assignee Address: DE Darmstadt GB London
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP14002929 20140822
- International Application: PCT/EP2015/001570 WO 20150730
- International Announcement: WO2016/026549 WO 20160225
- Main IPC: C07D403/06
- IPC: C07D403/06 ; C07D471/04 ; A61K31/55 ; A61K31/437 ; A61K31/444 ; A61K31/454 ; A61K31/4184 ; A61K31/4545 ; A61K31/5377 ; C07D401/06
Abstract:
The invention provides novel substituted indazole compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
Public/Granted literature
- US20170267675A1 INDAZOLES Public/Granted day:2017-09-21
Information query
